Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GLOBAL CORD BLOOD CORPORATION

(CO)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Global Cord Blood Mulls Acquisitions

08/31/2021 | 08:00am EDT

Global Cord Blood Corporation (NYSE:CO) will look or acquisitions. Chief Financial Officer Bing Chuen Chen said, "The capital on hand, as you are aware, is in excess of RMB 6 billion and half of which or close to half of which are as the result of people electing to pay the upfront payment option, which results in deferred revenue. Fair to say that the company right now is in a relatively strong financial position to potentially withstand any potential regulatory changes in the cord blood banking industry in China as well as the -- our ability to potential take on additional acquisitions or diversification projects".


© S&P Capital IQ 2021
All news about GLOBAL CORD BLOOD CORPORATION
09/17GLOBAL CORD BLOOD CORPORATION : to Hold Annual General Meeting in Hong Kong on December 7,..
PR
08/31Global Cord Blood Mulls Acquisitions
CI
08/30GLOBAL CORD BLOOD : Q1 Fiscal 2022 Financial Results
PU
08/30GLOBAL CORD BLOOD : Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-..
PU
08/30GLOBAL CORD BLOOD : Fiscal Q1 Earnings Snapshot
AQ
08/30GLOBAL CORD BLOOD : Earnings Flash (CO) GLOBAL CORD BLOOD CORPORATION Posts Q1 EPS $0.17
MT
08/30GLOBAL CORD BLOOD CORPORATION : Reports Financial Results for the First Quarter of Fiscal ..
PR
08/25GLOBAL CORD BLOOD CORPORATION : to Report First Quarter Fiscal 2022 Financial Results
PR
07/29GLOBAL CORD BLOOD CORPORATION : Files Annual Report on Form 20-F
PR
06/29Global Cord Blood Seeks Acquisitions
CI
More news
Financials (USD)
Sales 2021 1 160 M 181 M 181 M
Net income 2021 508 M 79,5 M 79,5 M
Net cash 2021 6 074 M 950 M 950 M
P/E ratio 2021 1,08x
Yield 2021 -
Capitalization 3 388 M 530 M 530 M
EV / Sales 2020 -2,24x
EV / Sales 2021 -2,13x
Nbr of Employees 1 215
Free-Float 28,4%
Chart GLOBAL CORD BLOOD CORPORATION
Duration : Period :
Global Cord Blood Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBAL CORD BLOOD CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Ting Zheng Chairman & Chief Executive Officer
Bing Chuen Chen Chief Financial Officer & Director
Xin Xu Chief Technology Officer
Jennifer J. Weng Independent Non-Executive Director
Jack S. L. Chow Independent Non-Executive Director